Clinical Trials Directory

Trials / Completed

CompletedNCT04194918

Flexiquit+: Web Program to Promote Smoking Cessation in Sexual and Gender Minority Young Adult Smokers

A Scalable E-Health Smoking Cessation Intervention for Sexual and Gender Minority Young Adults

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

This phase I trial studies how well Flexiquit+ helps young adult smokers who identify as a sexual and/or gender minority to quit or cut down on smoking. Flexiquit+ is an avatar-led, web-based intervention that can help smokers quit or cut back on how much they smoke cigarettes and/or vape, reducing their chances of developing tobacco-related health conditions.

Detailed description

OUTLINE: Individuals will be recruited to use the Flexiquit+ program consisting of 6 sessions, each lasting approximately 25 minutes. Participants will also receive text messages providing motivational messages and review information discussed in the program. At the end of the intervention, participants will receive an email with all of the session handouts. Participants are followed up with at 2 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALComputer-Assisted Smoking Cessation InterventionUse the Flexiquit+ program
OTHERText MessageReceive text messages
OTHERHandoutReceive handouts via email
OTHERQuestionnaire AdministrationAncillary studies
OTHERQuality-of-Life AssessmentAncillary studies
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2020-05-18
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2019-12-11
Last updated
2020-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04194918. Inclusion in this directory is not an endorsement.